PetVivo Holdings Inc (PETV) - Total Assets
Based on the latest financial reports, PetVivo Holdings Inc (PETV) holds total assets worth $6.89 Million USD as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore PetVivo Holdings Inc (PETV) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
PetVivo Holdings Inc - Total Assets Trend (2011–2025)
This chart illustrates how PetVivo Holdings Inc's total assets have evolved over time, based on quarterly financial data. See PETV book value for net asset value and shareholders' equity analysis.
PetVivo Holdings Inc - Asset Composition Analysis
Current Asset Composition (March 2025)
PetVivo Holdings Inc's total assets of $6.89 Million consist of 60.1% current assets and 39.9% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 2.4% |
| Accounts Receivable | $4.46 Million | 47.8% |
| Inventory | $323.50K | 3.5% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $1.97 Million | 21.1% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2011–2025)
This chart illustrates how PetVivo Holdings Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market cap of PetVivo Holdings Inc.
Key Asset Composition Facts
- Current vs. Non-Current Assets: PetVivo Holdings Inc's current assets represent 60.1% of total assets in 2025, a decrease from 100.0% in 2011.
- Cash Position: Cash and equivalents constituted 2.4% of total assets in 2025, down from 28.5% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 21.0% of total assets, an increase from 0.0% in 2011.
- Asset Diversification: The largest asset category is accounts receivable at 47.8% of total assets.
PetVivo Holdings Inc Competitors by Total Assets
Key competitors of PetVivo Holdings Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Bio-Rad Laboratories Inc
NYSE:BIO
|
USA | $9.79 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
Tellgen Corp
SHE:300642
|
China | CN¥2.01 Billion |
|
Affluent Medical SAS
PA:AFME
|
France | €59.84 Million |
|
Cochlear Ltd
AU:COH
|
Australia | AU$2.83 Billion |
|
4DMEDICAL Ltd
AU:4DX
|
Australia | AU$139.55 Million |
|
Anteris Technologies Global Corp
AU:AVR
|
Australia | AU$19.07 Million |
|
Imricor Medical Systems Inc
AU:IMR
|
Australia | AU$45.79 Million |
PetVivo Holdings Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.41 | 0.81 | 0.13 |
| Quick Ratio | 1.24 | 0.46 | 0.13 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $1.28 Million | $-211.12K | $-1.97 Million |
PetVivo Holdings Inc - Advanced Valuation Insights
This section examines the relationship between PetVivo Holdings Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 11.36 |
| Latest Market Cap to Assets Ratio | 3.77 |
| Asset Growth Rate (YoY) | 199.8% |
| Total Assets | $9.34 Million |
| Market Capitalization | $35.24 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values PetVivo Holdings Inc's assets at a significant premium (3.77x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: PetVivo Holdings Inc's assets grew by 199.8% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for PetVivo Holdings Inc (2011–2025)
The table below shows the annual total assets of PetVivo Holdings Inc from 2011 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | $9.34 Million | +199.79% |
| 2024-03-31 | $3.12 Million | +27.73% |
| 2023-03-31 | $2.44 Million | -67.16% |
| 2022-03-31 | $7.43 Million | +789.24% |
| 2021-03-31 | $835.25K | +59.85% |
| 2020-03-31 | $522.52K | -24.40% |
| 2019-03-31 | $691.15K | -55.92% |
| 2018-03-31 | $1.57 Million | -17.35% |
| 2017-03-31 | $1.90 Million | -88.63% |
| 2016-03-31 | $16.69 Million | +2087.74% |
| 2015-03-31 | $762.86K | +330.17% |
| 2014-03-31 | $177.34K | +146.47% |
| 2013-03-31 | $71.95K | +5221.89% |
| 2012-03-31 | $1.35K | -63.84% |
| 2011-03-31 | $3.74K | -- |
About PetVivo Holdings Inc
PetVivo Holdings, Inc., a biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals in the United States. The company's lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. It also provides therapeutic devices for … Read more